Female gonadal function before and after treatment of acromegaly

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages 4518-4525

  Grynberg, Michaël ^a,b   Salenave, Sylvie ^a   Young, Jacques ^a,b,c   Chanson, Philippe ^a,b,c  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; ESTRADIOL; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; PEGVISOMANT; PROLACTIN; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADOLESCENT; ADULT; ANOVULATION; ARTICLE; CANCER RADIOTHERAPY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE GENITAL SYSTEM; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; FUNCTIONAL ASSESSMENT; GALACTORRHEA; GROWTH HORMONE BLOOD LEVEL; HIRSUTISM; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; HYPOPHYSIS ADENOMA; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENSTRUATION; OVARY; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PREGNANT WOMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL;

EID: 77957785507     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2815     Document Type: Article

References (50)

1. Kaltsas GA, Mukherjee JJ, Jenkins PJ, Satta MA, Islam N, Monson JP, Besser GM, Grossman AB 1999 Menstrual irregularity inwomen with acromegaly. J Clin Endocrinol Metab 84:2731-2735
2. Katznelson L, Kleinberg D, Vance ML, Stavrou S, Pulaski KJ, Schoenfeld DA, Hayden DL, Wright ME, Woodburn CJ, Klibanski A, Stravou S 2001 Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Clin Endocrinol (Oxf) 54:183-188
3. Luboshitzky R, Dickstein G, Barzilai D 1980 Bromocriptine-induced pregnancy in an acromegalic patient. JAMA 244:584-586
4. Nabarro JD 1987 Acromegaly. Clin Endocrinol (Oxf) 26:481-512
5. Bigazzi M, Ronga R, Lancranjan I, Ferraro S, Branconi F, Buzzoni P, Martorana G, Scarselli GF, Del Pozo E 1979 A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartments. J Clin Endocrinol Metab 48:9-12
6. Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR 2000 The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab 85:1789-1793
7. Colao A, Lombardi G 1998 Growth-hormone and prolactin excess. Lancet 352:1455-1461
8. Chanson P, Salenave S, Kamenicky P, Cazabat L, Young J 2009 Pituitary tumours: acromegaly. Best Pract Res Clin Endocrinol Metab 23:555-574
9. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S 2000 Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529
10. Chanson P, Daujat F, Young J, Bellucci A, Kujas M, Doyon D, Schaison G 2001 Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study. J Clin Endocrinol Metab 86:3009-3015
11. Kamenicky P, Dos Santos C, Espinosa C, Salenave S, Galland F, Le Bouc Y, Maison P, Bougnères P, Chanson P 2009 D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly. Eur J Endocrinol 161:231-235
12. Galland F, Kamenicky P, Affres H, Reznik Y, Pontvert D, Le Bouc Y, Young J, Chanson P 2006 McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients. J Clin Endocrinol Metab 91:4957-4961
13. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
14. Prabhakar VK, Shalet SM 2006 Aetiology, diagnosis, and management of hypopituitarism in adult life. Postgrad Med J 82:259-266
15. Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E 2007 Hypopituitarism. Lancet 369:1461-1470
16. Pavord SR, Girach A, Price DE, Absalom SR, Falconer-Smith J, Howlett TA 1992 A retrospective audit of the combined pituitary function test, using the insulin stress test, TRH and GnRH in a district laboratory. Clin Endocrinol (Oxf) 36:135-139
17. Wentz AC, Jones GS, Rocco L, Matthews RR 1975 Gonadotropin response to luteinizing hormone releasing hormone administration in secondary amenorrhea and galactorrhea syndromes. Obstet Gynecol 45:256-262
18. Jadresic A, Banks LM, Child DF, Diamant L, Doyle FH, Fraser TR, Joplin GF 1982 The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q J Med 51:189-204
19. Arafah BM 1986 Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 62:1173-1179
20. Asa SL, Ezzat S 2002 The pathogenesis of pituitary tumours. Nat Rev Cancer 2:836-849
21. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A 2006 Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65:265-273
22. Lackey BR, Gray SL, Henricks DM 1999 The insulin-like growth factor (IGF) system and gonadotropin regulation: actions and interactions. Cytokine Growth Factor Rev 10:201-217
23. Hiney JK, Ojeda SR, Dees WL 1991 Insulin-like growth factor I: a possible metabolic signal involved in the regulation of female puberty. Neuroendocrinology 54:420-423
24. Hiney JK, Srivastava V, Nyberg CL, Ojeda SR, Dees WL 1996 Insulin-like growth factor I of peripheral origin acts centrally to accelerate the initiation of female puberty. Endocrinology 137:3717-3728
25. Chandrashekar V, Bartke A, Coschigano KT, Kopchick JJ 1999 Pituitary and testicular function in growth hormone receptor gene knockout mice. Endocrinology 140:1082-1088
26. Chandrashekar V, Bartke A, Awoniyi CA, Tsai-Morris CH, Dufau ML, Russell LD, Kopchick JJ 2001 Testicular endocrine function in GH receptor gene disrupted mice. Endocrinology 142:3443-3450
27. Bourguignon JP, Alvarez Gonzalez ML, Gerard A, Franchimont P 1994 Gonadotropin releasing hormone inhibitory autofeedback by subproducts antagonist at N-methyl-D-aspartate receptors: a model of autocrine regulation of peptide secretion. Endocrinology 134:1589-1592
28. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268
29. Kleinberg DL, Todd J 1980 Evidence that human growth hormone is a potent lactogen in primates. J Clin Endocrinol Metab 51:1009-1013
30. Gillam MP, Molitch ME, Lombardi G, Colao A 2006 Advances in the treatment of prolactinomas. Endocr Rev 27:485-534
31. Kaltsas GA, Androulakis, II, Tziveriotis K, Papadogias D, Tsikini A, Makras P, Dimitriou K, Stathopoulou A, Piaditis G 2007 Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clin Endocrinol (Oxf) 67:917-922
32. Hashimoto S, Yatabe J, Midorikawa S, Sanada H, Watanabe T 2003 Inhibition of growth hormone excess reduces insulin resistance and ovarian dysfunction in a lean case of polycystic ovary syndrome with a growth-hormone-producing pituitary adenoma. Horm Res 59:149-155
33. Barbieri RL, Smith S, Ryan KJ 1988 The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 50:197-212
34. Cara JF, Rosenfield RL 1988 Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 123:733-739
35. Møller N, Schmitz O, Jøorgensen JO, Astrup J, Bak JF, Christensen SE, Alberti KG, Weeke J 1992 Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab 74:1012-1019
36. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG 1991 A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72:83-89
37. Nestler JE, Jakubowicz DJ 1996 Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335:617-623
38. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
39. Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352:1223-1236
40. Norman RJ, Dewailly D, Legro RS, Hickey TE 2007 Polycystic ovary syndrome. Lancet 370:685-697
41. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
42. Franks S, Robinson S, Willis DS 1996 Nutrition, insulin and polycystic ovary syndrome. Rev Reprod 1:47-53
43. Homburg R, Eshel A, Abdalla HI, Jacobs HS 1988 Growth hormone facilitates ovulation induction by gonadotrophins. Clin Endocrinol (Oxf) 29:113-117
44. Burger HG, Kovacs GT, Polson DM, McDonald J, McCloud PI, Harrop M, Colman P, Healy DL 1991 Ovarian sensitization to gonadotrophins by human growth hormone. Persistence of the effect beyond the treated cycle. Clin Endocrinol (Oxf) 35:119-122
45. Katz E, Ricciarelli E, Adashi EY 1993 The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil Steril 59:8-34
46. Mason HD, Martikainen H, Beard RW, Anyaoku V, Franks S 1990 Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells in vitro. J Endocrinol 126:R1-R4
47. Carlsson B, Bergh C, Bentham J, Olsson JH, Norman MR, Billig H, Roos P, Hillensjö T 1992 Expression of functional growth hormone receptors in human granulosa cells. Hum Reprod 7:1205-1209
48. Erickson GF, Garzo VG, Magoffin DA 1989 Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells. J Clin Endocrinol Metab 69:716-724
49. Juul A, Scheike T, Pedersen AT, Main KM, Andersson AM, Pedersen LM, Skakkebaek NE 1997 Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. Hum Reprod 12:2123-2128
50. Giudice LC 1992 Insulin-like growth factors and ovarian follicular development. Endocr Rev 13:641-669